Details of the Drug

General Information of Drug (ID: DMWXYX9)

• Drug Name: Kanglaite

Indication

Disease Entry	ICD 11	Status	REF
Cachexia	MG20	Phase 1	[1]

• Cross-matching ID: TTD ID: D0XV6L

References

• [1] ClinicalTrials.gov (NCT00031031) Kanglaite Injection Phase I Study. U.S. National Institutes of Health.